9.9M XNAS Volume
XNAS 18 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Andrew D. Dickinson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 11,090 | 38,609 | - | - | Restricted Stock Unit | |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 63.91 per share. | 10 Mar 2025 | 4,916 | 173,977 (0%) | 0% | 63.9 | 314,182 | Common Stock |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 63.91 per share. | 10 Mar 2025 | 13,013 | 186,990 (0%) | 0% | 63.9 | 831,661 | Common Stock |
| Andrew D. Dickinson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 117.30 per share. | 10 Mar 2025 | 4,916 | 182,074 (0%) | 0% | 117.3 | 576,641 | Common Stock |
| Andrew D. Dickinson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 118.50 per share. | 10 Mar 2025 | 13,013 | 169,061 (0%) | 0% | 118.5 | 1,542,055 | Common Stock |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 7,968 | 177,029 (0%) | 0% | - | Common Stock | |
| Andrew D. Dickinson | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 117.21 per share. | 10 Mar 2025 | 3,855 | 173,174 (0%) | 0% | 117.2 | 451,845 | Common Stock |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 4,916 | 13,013 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 13,013 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 7,968 | 27,519 | - | - | Restricted Stock Unit | |
| Andrew D. Dickinson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 49,020 | 49,020 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Daniel P. O'Day | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 38,395 | 119,348 | - | - | Restricted Stock Unit | |
| Daniel P. O'Day | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 169,690 | 169,690 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Daniel P. O'Day | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 24,024 | 80,953 | - | - | Restricted Stock Unit | |
| Daniel P. O'Day | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 117.21 per share. | 10 Mar 2025 | 11,632 | 630,268 (0%) | 0% | 117.2 | 1,363,387 | Common Stock |
| Daniel P. O'Day | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 24,024 | 641,900 (0%) | 0% | - | Common Stock | |
| Dietmar Berger | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 8,530 | 57,505 | - | - | Restricted Stock Unit | |
| Dietmar Berger | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 37,710 | 37,710 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Johanna Mercier | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 117.21 per share. | 10 Mar 2025 | 3,907 | 124,152 (0%) | 0% | 117.2 | 457,939 | Common Stock |
| Johanna Mercier | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 8,080 | 28,113 | - | - | Restricted Stock Unit | |
| Johanna Mercier | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 49,020 | 49,020 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Johanna Mercier | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 11,090 | 39,203 | - | - | Restricted Stock Unit | |
| Johanna Mercier | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 8,080 | 128,059 (0%) | 0% | - | Common Stock | |
| Deborah H. Telman | EVP, Corporate Affairs & GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 3,343 | 37,692 (0%) | 0% | - | Common Stock | |
| Deborah H. Telman | EVP, Corporate Affairs & GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 3,343 | 24,356 | - | - | Restricted Stock Unit | |
| Deborah H. Telman | EVP, Corporate Affairs & GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 33,940 | 33,940 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Deborah H. Telman | EVP, Corporate Affairs & GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 7,680 | 32,216 | - | - | Restricted Stock Unit | |
| Deborah H. Telman | EVP, Corporate Affairs & GC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 117.21 per share. | 10 Mar 2025 | 1,130 | 36,562 (0%) | 0% | 117.2 | 132,447 | Common Stock |
| Sandra Patterson | SVP, Controllership | Payment of exercise price or tax liability using portion of securities received from the company at price $ 117.21 per share. | 10 Mar 2025 | 624 | 39,453 (0%) | 0% | 117.2 | 73,139 | Common Stock |
| Sandra Patterson | SVP, Controllership | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 1,952 | 9,875 | - | - | Restricted Stock Unit | |
| Sandra Patterson | SVP, Controllership | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 1,952 | 40,077 (0%) | 0% | - | Common Stock | |
| Andrew D. Dickinson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 104.09 per share. | 18 Feb 2025 | 2,500 | 169,061 (0%) | 0% | 104.1 | 260,225 | Common Stock |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 18,210 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 15,600 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 77,691 | 17,929 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Andrew D. Dickinson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 102.22 per share. | 12 Feb 2025 | 137,676 | 171,223 (0%) | 0% | 102.2 | 14,073,241 | Common Stock |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 83.49 per share. | 12 Feb 2025 | 18,210 | 308,899 (0%) | 0% | 83.5 | 1,520,353 | Common Stock |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 80.72 per share. | 12 Feb 2025 | 15,600 | 290,689 (0%) | 0% | 80.7 | 1,259,232 | Common Stock |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.92 per share. | 12 Feb 2025 | 26,175 | 275,089 (0%) | 0% | 57.9 | 1,516,056 | Common Stock |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 63.91 per share. | 12 Feb 2025 | 77,691 | 248,914 (0%) | 0% | 63.9 | 4,965,232 | Common Stock |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 26,175 | 78,515 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Andrew D. Dickinson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2025 | 19,793 | 149,666 (0%) | 0% | 0 | Common Stock | |
| Andrew D. Dickinson | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 97.99 per share. | 04 Feb 2025 | 43,138 | 171,223 (0%) | 0% | 98.0 | 4,227,093 | Common Stock |
| Andrew D. Dickinson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2025 | 64,695 | 214,361 (0%) | 0% | 0 | Common Stock | |
| Daniel P. O'Day | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2025 | 164,473 | 726,032 (0%) | 0% | 0 | Common Stock | |
| Daniel P. O'Day | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2025 | 60,031 | 561,559 (0%) | 0% | 0 | Common Stock | |
| Daniel P. O'Day | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 97.99 per share. | 04 Feb 2025 | 108,156 | 617,876 (0%) | 0% | 98.0 | 10,598,206 | Common Stock |
| Johanna Mercier | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2025 | 70,712 | 165,645 (0%) | 0% | 0 | Common Stock | |
| Johanna Mercier | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 97.99 per share. | 04 Feb 2025 | 45,666 | 119,979 (0%) | 0% | 98.0 | 4,474,811 | Common Stock |
| Johanna Mercier | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2025 | 19,793 | 94,933 (0%) | 0% | 0 | Common Stock | |
| Deborah H. Telman | EVP, Corporate Affairs & GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2025 | 12,371 | 34,011 (0%) | 0% | 0 | Common Stock | |
| Sandra Patterson | SVP, Controllership | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2025 | 709 | 37,787 (0%) | 0% | 0 | Common Stock | |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2025 | 44,160 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 65.38 per share. | 31 Jan 2025 | 44,160 | 273,053 (0%) | 0% | 65.4 | 2,887,181 | Common Stock |
| Andrew D. Dickinson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 97.22 per share. | 31 Jan 2025 | 142,180 | 129,873 (0%) | 0% | 97.2 | 13,822,740 | Common Stock |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2025 | 26,170 | 104,690 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2025 | 71,850 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.92 per share. | 31 Jan 2025 | 26,170 | 156,043 (0%) | 0% | 57.9 | 1,515,766 | Common Stock |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 72.34 per share. | 31 Jan 2025 | 71,850 | 227,893 (0%) | 0% | 72.3 | 5,197,629 | Common Stock |
| Deborah H. Telman | EVP, Corporate Affairs & GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2025 | 515 | 21,827 (0%) | 0% | - | Common Stock | |
| Deborah H. Telman | EVP, Corporate Affairs & GC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 93.07 per share. | 25 Jan 2025 | 187 | 21,640 (0%) | 0% | 93.1 | 17,404 | Common Stock |
| Deborah H. Telman | EVP, Corporate Affairs & GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2025 | 515 | 27,879 | - | - | Restricted Stock Unit | |
| Andrew D. Dickinson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 91.35 per share. | 15 Jan 2025 | 2,500 | 129,873 (0%) | 0% | 91.4 | 228,375 | Common Stock |
| Dietmar Berger | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 48,975 | 48,975 | - | - | Restricted Stock Unit | |
| Andrew D. Dickinson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 91.96 per share. | 16 Dec 2024 | 8,500 | 132,373 (0%) | 0% | 92.0 | 781,660 | Common Stock |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2024 | 3,640 | 142,559 (0%) | 0% | - | Common Stock | |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2024 | 3,640 | 35,487 | - | - | Restricted Stock Unit | |
| Andrew D. Dickinson | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.34 per share. | 10 Dec 2024 | 1,686 | 140,873 (0%) | 0% | 92.3 | 155,685 | Common Stock |
| Daniel P. O'Day | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2024 | 10,295 | 506,290 (0%) | 0% | - | Common Stock | |
| Daniel P. O'Day | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2024 | 10,295 | 104,977 | - | - | Restricted Stock Unit | |
| Daniel P. O'Day | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.34 per share. | 10 Dec 2024 | 4,762 | 501,528 (0%) | 0% | 92.3 | 439,723 | Common Stock |
| Johanna Mercier | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2024 | 3,752 | 36,193 | - | - | Restricted Stock Unit | |
| Johanna Mercier | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2024 | 3,752 | 76,879 (0%) | 0% | - | Common Stock | |
| Johanna Mercier | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.34 per share. | 10 Dec 2024 | 1,739 | 75,140 (0%) | 0% | 92.3 | 160,579 | Common Stock |
| Merdad V. Parsey | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2024 | 3,820 | 36,753 | - | - | Restricted Stock Unit | |
| Merdad V. Parsey | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.34 per share. | 10 Dec 2024 | 1,771 | 82,850 (0%) | 0% | 92.3 | 163,534 | Common Stock |
| Merdad V. Parsey | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2024 | 3,820 | 84,621 (0%) | 0% | - | Common Stock | |
| Deborah H. Telman | EVP, Corporate Affairs & GC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.34 per share. | 10 Dec 2024 | 306 | 21,312 (0%) | 0% | 92.3 | 28,256 | Common Stock |
| Deborah H. Telman | EVP, Corporate Affairs & GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2024 | 639 | 28,394 | - | - | Restricted Stock Unit | |
| Deborah H. Telman | EVP, Corporate Affairs & GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2024 | 639 | 21,618 (0%) | 0% | - | Common Stock | |
| Sandra Patterson | SVP, Controllership | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2024 | 901 | 12,282 | - | - | Restricted Stock Unit | |
| Sandra Patterson | SVP, Controllership | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2024 | 901 | 37,486 (0%) | 0% | - | Common Stock | |
| Sandra Patterson | SVP, Controllership | Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.34 per share. | 10 Dec 2024 | 408 | 37,078 (0%) | 0% | 92.3 | 37,675 | Common Stock |
| Andrew D. Dickinson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 92.76 per share. | 29 Nov 2024 | 127,930 | 138,919 (0%) | 0% | 92.8 | 11,867,119 | Common Stock |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Nov 2024 | 65,960 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Nov 2024 | 43,340 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Nov 2024 | 60,885 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Nov 2024 | 33,660 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Nov 2024 | 18,630 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Nov 2024 | 26,170 | 130,860 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Andrew D. Dickinson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 92.77 per share. | 29 Nov 2024 | 120,715 | 266,849 (0%) | 0% | 92.8 | 11,198,151 | Common Stock |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 72.70 per share. | 29 Nov 2024 | 65,960 | 387,564 (0%) | 0% | 72.7 | 4,795,292 | Common Stock |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 72.70 per share. | 29 Nov 2024 | 43,340 | 321,604 (0%) | 0% | 72.7 | 3,150,818 | Common Stock |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 71.91 per share. | 29 Nov 2024 | 60,885 | 278,264 (0%) | 0% | 71.9 | 4,378,240 | Common Stock |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 68.75 per share. | 29 Nov 2024 | 33,660 | 217,379 (0%) | 0% | 68.8 | 2,314,125 | Common Stock |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.92 per share. | 29 Nov 2024 | 26,170 | 183,719 (0%) | 0% | 57.9 | 1,515,766 | Common Stock |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 73.77 per share. | 29 Nov 2024 | 18,630 | 157,549 (0%) | 0% | 73.8 | 1,374,335 | Common Stock |
| Merdad Parsey V. | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 91.80 per share. | 27 Nov 2024 | 3,199 | 91,200 (0%) | 0% | 91.8 | 293,679 | Common Stock |
| Parsey Merdad V. | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 92.00 per share. | 27 Nov 2024 | 88,119 | 99,599 (0%) | 0% | 92 | 8,106,948 | Common Stock |
| V. Merdad Parsey | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 91.79 per share. | 27 Nov 2024 | 57,294 | 187,718 (0%) | 0% | 91.8 | 5,259,297 | Common Stock |
| Parsey V. Merdad | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Nov 2024 | 88,119 | 196 | - | - | Non-qualified Stock Option (Right to Buy) | |
| V. Merdad Parsey | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Nov 2024 | 57,294 | 64,376 | - | - | Non-qualified Stock Option (Right to Buy) | |
| V. Merdad Parsey | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 65.38 per share. | 27 Nov 2024 | 88,119 | 245,012 (0%) | 0% | 65.4 | 5,761,220 | Common Stock |
| Merdad Parsey V. | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.92 per share. | 27 Nov 2024 | 57,294 | 156,893 (0%) | 0% | 57.9 | 3,318,468 | Common Stock |
| Parsey V. Merdad | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 91.80 per share. | 27 Nov 2024 | 5,200 | 94,399 (0%) | 0% | 91.8 | 477,381 | Common Stock |
| Parsey V. Merdad | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 92.00 per share. | 27 Nov 2024 | 10,399 | 80,801 (0%) | 0% | 92 | 956,708 | Common Stock |
| Bluestone A. Jeffrey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Nov 2024 | 4,121 | 11,730 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Jeffrey A. Bluestone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Nov 2024 | 5,879 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| A. Bluestone Jeffrey | Director | Sale of securities on an exchange or to another person at price $ 91.39 per share. | 26 Nov 2024 | 6,788 | 8,920 (0%) | 0% | 91.4 | 620,356 | Common Stock |
| A. Bluestone Jeffrey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 61.35 per share. | 26 Nov 2024 | 4,121 | 15,708 (0%) | 0% | 61.3 | 252,823 | Common Stock |
| Jeffrey Bluestone A. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 61.17 per share. | 26 Nov 2024 | 5,879 | 11,587 (0%) | 0% | 61.2 | 359,618 | Common Stock |
| Merdad V. Parsey | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 91.50 per share. | 06 Nov 2024 | 20,590 | 104,599 (0%) | 0% | 91.5 | 1,883,985 | Common Stock |
| Johanna Mercier | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 91.28 per share. | 06 Nov 2024 | 5,000 | 73,127 (0%) | 0% | 91.3 | 456,400 | Common Stock |
| Merdad V. Parsey | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.92 per share. | 06 Nov 2024 | 25,000 | 125,189 (0%) | 0% | 57.9 | 1,448,000 | Common Stock |
| Merdad V. Parsey | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Nov 2024 | 25,000 | 121,670 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Merdad V. Parsey | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 91.50 per share. | 06 Nov 2024 | 5,000 | 99,599 (0%) | 0% | 91.5 | 457,500 | Common Stock |
| Deborah H. Telman | EVP, Corporate Affairs & GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Oct 2024 | 514 | 29,033 | - | - | Restricted Stock Unit | |
| Deborah H. Telman | EVP, Corporate Affairs & GC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.00 per share. | 25 Oct 2024 | 242 | 20,979 (0%) | 0% | 89 | 21,538 | Common Stock |
| Deborah H. Telman | EVP, Corporate Affairs & GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Oct 2024 | 514 | 21,221 (0%) | 0% | - | Common Stock | |
| Merdad V. Parsey | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 83.83 per share. | 01 Oct 2024 | 2,000 | 100,189 (0%) | 0% | 83.8 | 167,660 | Common Stock |
| Johanna Mercier | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 84.23 per share. | 12 Sep 2024 | 15,925 | 91,559 (0%) | 0% | 84.2 | 1,341,363 | Common Stock |
| Johanna Mercier | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 83.25 per share. | 12 Sep 2024 | 13,432 | 78,127 (0%) | 0% | 83.3 | 1,118,214 | Common Stock |
| Merdad V. Parsey | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Sep 2024 | 25,000 | 146,670 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Merdad V. Parsey | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 84.50 per share. | 12 Sep 2024 | 21,246 | 102,189 (0%) | 0% | 84.5 | 1,795,287 | Common Stock |
| Merdad V. Parsey | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.92 per share. | 12 Sep 2024 | 25,000 | 123,435 (0%) | 0% | 57.9 | 1,448,000 | Common Stock |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2024 | 3,641 | 140,601 (0%) | 0% | - | Common Stock | |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2024 | 3,641 | 39,127 | - | - | Restricted Stock Unit | |
| Andrew D. Dickinson | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.44 per share. | 10 Sep 2024 | 1,682 | 138,919 (0%) | 0% | 81.4 | 136,982 | Common Stock |
| Daniel P. O'Day | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2024 | 10,295 | 500,744 (0%) | 0% | - | Common Stock | |
| Daniel P. O'Day | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2024 | 10,295 | 115,272 | - | - | Restricted Stock Unit | |
| Daniel P. O'Day | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.44 per share. | 10 Sep 2024 | 4,749 | 495,995 (0%) | 0% | 81.4 | 386,759 | Common Stock |
| Johanna Mercier | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.44 per share. | 10 Sep 2024 | 1,734 | 107,484 (0%) | 0% | 81.4 | 141,217 | Common Stock |
| Johanna Mercier | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2024 | 3,752 | 39,945 | - | - | Restricted Stock Unit | |
| Johanna Mercier | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2024 | 3,752 | 109,218 (0%) | 0% | - | Common Stock | |
| Merdad V. Parsey | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.44 per share. | 10 Sep 2024 | 1,766 | 98,435 (0%) | 0% | 81.4 | 143,823 | Common Stock |
| Merdad V. Parsey | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2024 | 3,821 | 40,573 | - | - | Restricted Stock Unit | |
| Merdad V. Parsey | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2024 | 3,821 | 100,201 (0%) | 0% | - | Common Stock | |
| Deborah H. Telman | EVP, Corporate Affairs & GC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.44 per share. | 10 Sep 2024 | 307 | 20,707 (0%) | 0% | 81.4 | 25,002 | Common Stock |
| Deborah H. Telman | EVP, Corporate Affairs & GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2024 | 639 | 21,014 (0%) | 0% | - | Common Stock | |
| Deborah H. Telman | EVP, Corporate Affairs & GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2024 | 639 | 29,547 | - | - | Restricted Stock Unit | |
| Sandra Patterson | SVP, Controllership | Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.44 per share. | 10 Sep 2024 | 292 | 36,585 (0%) | 0% | 81.4 | 23,780 | Common Stock |
| Sandra Patterson | SVP, Controllership | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2024 | 901 | 13,183 | - | - | Restricted Stock Unit | |
| Sandra Patterson | SVP, Controllership | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2024 | 901 | 36,877 (0%) | 0% | - | Common Stock | |
| Johanna Mercier | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 78.03 per share. | 28 Aug 2024 | 9,513 | 105,466 (0%) | 0% | 78.0 | 742,299 | Common Stock |
| Johanna Mercier | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 73.98 per share. | 13 Aug 2024 | 5,490 | 114,979 (0%) | 0% | 74.0 | 406,150 | Common Stock |
| Sandra Patterson | SVP, Controllership | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2024 | 3,678 | 14,084 | - | - | Restricted Stock Unit | |
| Sandra Patterson | SVP, Controllership | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2024 | 3,678 | 36,956 (0%) | 0% | - | Common Stock | |
| Sandra Patterson | SVP, Controllership | Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.66 per share. | 10 Aug 2024 | 980 | 35,976 (0%) | 0% | 73.7 | 72,187 | Common Stock |
| Deborah H. Telman | EVP, Corporate Affairs & GC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 76.51 per share. | 25 Jul 2024 | 2,917 | 11,631 (0%) | 0% | 76.5 | 223,180 | Common Stock |
| Deborah H. Telman | EVP, Corporate Affairs & GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jul 2024 | 514 | 12,145 (0%) | 0% | - | Common Stock | |
| Deborah H. Telman | EVP, Corporate Affairs & GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jul 2024 | 8,230 | 20,375 (0%) | 0% | - | Common Stock | |
| Deborah H. Telman | EVP, Corporate Affairs & GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jul 2024 | 514 | 38,416 | - | - | Restricted Stock Unit | |
| Deborah H. Telman | EVP, Corporate Affairs & GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jul 2024 | 8,230 | 30,186 | - | - | Restricted Stock Unit | |
| Merdad V. Parsey | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 68.63 per share. | 01 Jul 2024 | 2,000 | 96,380 (0%) | 0% | 68.6 | 137,260 | Common Stock |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2024 | 3,639 | 138,622 (0%) | 0% | - | Common Stock | |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2024 | 3,639 | 42,768 | - | - | Restricted Stock Unit | |
| Andrew D. Dickinson | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.25 per share. | 10 Jun 2024 | 1,662 | 136,960 (0%) | 0% | 65.3 | 108,446 | Common Stock |
| Daniel P. O'Day | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2024 | 10,295 | 125,567 | - | - | Restricted Stock Unit | |
| Daniel P. O'Day | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2024 | 10,295 | 495,142 (0%) | 0% | - | Common Stock | |
| Daniel P. O'Day | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.25 per share. | 10 Jun 2024 | 4,693 | 490,449 (0%) | 0% | 65.2 | 306,218 | Common Stock |
| Johanna Mercier | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2024 | 3,751 | 122,183 (0%) | 0% | - | Common Stock | |
| Johanna Mercier | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2024 | 3,751 | 43,697 | - | - | Restricted Stock Unit | |
| Johanna Mercier | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.25 per share. | 10 Jun 2024 | 1,714 | 120,469 (0%) | 0% | 65.3 | 111,839 | Common Stock |
| Merdad V. Parsey | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2024 | 3,820 | 44,394 | - | - | Restricted Stock Unit | |
| Merdad V. Parsey | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.25 per share. | 10 Jun 2024 | 1,744 | 98,380 (0%) | 0% | 65.3 | 113,796 | Common Stock |
| Merdad V. Parsey | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2024 | 3,820 | 100,124 (0%) | 0% | - | Common Stock | |
| Deborah H. Telman | EVP, Corporate Affairs & GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2024 | 638 | 14,752 (0%) | 0% | - | Common Stock | |
| Deborah H. Telman | EVP, Corporate Affairs & GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2024 | 638 | 38,930 | - | - | Restricted Stock Unit | |
| Deborah H. Telman | EVP, Corporate Affairs & GC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.25 per share. | 10 Jun 2024 | 204 | 14,548 (0%) | 0% | 65.3 | 13,311 | Common Stock |
| Sandra Patterson | SVP, Controllership | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.25 per share. | 10 Jun 2024 | 255 | 33,278 (0%) | 0% | 65.3 | 16,639 | Common Stock |
| Sandra Patterson | SVP, Controllership | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2024 | 901 | 17,762 | - | - | Restricted Stock Unit | |
| Sandra Patterson | SVP, Controllership | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2024 | 901 | 33,533 (0%) | 0% | - | Common Stock | |
| Kelly Anne Kramer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 2,310 | 17,594 | - | - | Restricted Stock Unit | |
| Kelly Anne Kramer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 12,648 | 12,648 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Sandra J. Horning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 12,648 | 12,648 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Sandra J. Horning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 2,310 | 7,801 | - | - | Restricted Stock Unit | |
| Anthony Welters | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 2,310 | 10,232 (0%) | 0% | 0 | Common Stock | |
| Anthony Welters | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 12,648 | 12,648 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Jacqueline K. Barton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 2,310 | 24,540 (0%) | 0% | 0 | Common Stock | |
| Jacqueline K. Barton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 12,648 | 12,648 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Javier J. Rodriguez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 2,310 | 10,702 (0%) | 0% | 0 | Common Stock | |
| Javier J. Rodriguez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 12,648 | 12,648 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Ted W. Love | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 2,310 | 2,822 (0%) | 0% | 0 | Common Stock | |
| Ted W. Love | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 12,648 | 12,648 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Harish Manwani | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 64.92 per share. | 08 May 2024 | 451 | 12,873 (0%) | 0% | 64.9 | 29,279 | Common Stock |
| Harish Manwani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 12,648 | 12,648 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Harish Manwani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 2,310 | 13,324 (0%) | 0% | 0 | Common Stock | |
| Jeffrey A. Bluestone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 2,310 | 4,197 | - | - | Restricted Stock Unit | |
| Jeffrey A. Bluestone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 12,648 | 12,648 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Deborah H. Telman | EVP, Corporate Affairs & GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2024 | 515 | 39,568 | - | - | Restricted Stock Unit | |
| Deborah H. Telman | EVP, Corporate Affairs & GC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.27 per share. | 25 Apr 2024 | 158 | 14,114 (0%) | 0% | 65.3 | 10,313 | Common Stock |
| Deborah H. Telman | EVP, Corporate Affairs & GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2024 | 515 | 14,272 (0%) | 0% | - | Common Stock | |
| Merdad V. Parsey | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 72.96 per share. | 01 Apr 2024 | 2,000 | 96,304 (0%) | 0% | 73.0 | 145,920 | Common Stock |
| Andrew D. Dickinson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2024 | 17,305 | 46,407 | - | - | Restricted Stock Unit | |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 3,025 | 132,781 (0%) | 0% | - | Common Stock | |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 6,707 | 139,488 (0%) | 0% | - | Common Stock | |
| Andrew D. Dickinson | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.12 per share. | 10 Mar 2024 | 4,505 | 134,983 (0%) | 0% | 75.1 | 338,416 | Common Stock |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 3,025 | 35,040 | - | - | Restricted Stock Unit | |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 6,707 | 28,333 | - | - | Restricted Stock Unit | |
| Andrew D. Dickinson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2024 | 87,970 | 87,970 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Daniel O'Day | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 10,800 | 479,489 (0%) | 0% | - | Common Stock | |
| Daniel O'Day | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2024 | 54,910 | 135,862 | - | - | Restricted Stock Unit | |
| Daniel O'Day | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2024 | 279,130 | 279,130 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Daniel O'Day | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 19,140 | 80,952 | - | - | Restricted Stock Unit | |
| Daniel O'Day | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 10,800 | 100,092 | - | - | Restricted Stock Unit | |
| Daniel O'Day | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.12 per share. | 10 Mar 2024 | 13,782 | 484,847 (0%) | 0% | 75.1 | 1,035,304 | Common Stock |
| Daniel O'Day | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 19,140 | 498,629 (0%) | 0% | - | Common Stock | |
| Johanna Mercier | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 3,025 | 116,172 (0%) | 0% | - | Common Stock | |
| Johanna Mercier | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2024 | 17,305 | 47,448 | - | - | Restricted Stock Unit | |
| Johanna Mercier | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2024 | 87,970 | 87,970 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Johanna Mercier | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 6,819 | 30,143 | - | - | Restricted Stock Unit | |
| Johanna Mercier | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 3,025 | 36,962 | - | - | Restricted Stock Unit | |
| Johanna Mercier | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.12 per share. | 10 Mar 2024 | 4,559 | 118,432 (0%) | 0% | 75.1 | 342,472 | Common Stock |
| Johanna Mercier | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 6,819 | 122,991 (0%) | 0% | - | Common Stock | |
| Merdad V. Parsey | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 6,946 | 103,107 (0%) | 0% | - | Common Stock | |
| Merdad V. Parsey | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2024 | 17,640 | 48,214 | - | - | Restricted Stock Unit | |
| Merdad V. Parsey | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2024 | 89,660 | 89,660 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Merdad V. Parsey | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 6,946 | 30,574 | - | - | Restricted Stock Unit | |
| Merdad V. Parsey | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 3,455 | 37,520 | - | - | Restricted Stock Unit | |
| Merdad V. Parsey | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.12 per share. | 10 Mar 2024 | 4,803 | 98,304 (0%) | 0% | 75.1 | 360,801 | Common Stock |
| Merdad V. Parsey | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 3,455 | 96,161 (0%) | 0% | - | Common Stock | |
| Deborah H. Telman | EVP, Corporate Affairs & GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2024 | 10,815 | 40,083 | - | - | Restricted Stock Unit | |
| Deborah H. Telman | EVP, Corporate Affairs & GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 2,555 | 14,603 (0%) | 0% | - | Common Stock | |
| Deborah H. Telman | EVP, Corporate Affairs & GC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.12 per share. | 10 Mar 2024 | 846 | 13,757 (0%) | 0% | 75.1 | 63,552 | Common Stock |
| Deborah H. Telman | EVP, Corporate Affairs & GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 2,555 | 29,268 | - | - | Restricted Stock Unit | |
| Deborah H. Telman | EVP, Corporate Affairs & GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2024 | 54,980 | 54,980 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Sandra Patterson | SVP, Controllership | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 748 | 31,488 (0%) | 0% | - | Common Stock | |
| Sandra Patterson | SVP, Controllership | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 1,934 | 33,422 (0%) | 0% | - | Common Stock | |
| Sandra Patterson | SVP, Controllership | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.12 per share. | 10 Mar 2024 | 790 | 32,632 (0%) | 0% | 75.1 | 59,345 | Common Stock |
| Sandra Patterson | SVP, Controllership | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2024 | 4,825 | 18,663 | - | - | Restricted Stock Unit | |
| Sandra Patterson | SVP, Controllership | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2024 | 13,660 | 13,660 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Sandra Patterson | SVP, Controllership | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 1,934 | 13,838 | - | - | Restricted Stock Unit | |
| Sandra Patterson | SVP, Controllership | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 748 | 15,772 | - | - | Restricted Stock Unit | |
| Parsey Merdad V. | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 73.18 per share. | 28 Feb 2024 | 2,000 | 100,936 (0%) | 0% | 73.2 | 146,360 | Common Stock |
| Parsey V. Merdad | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 72.74 per share. | 28 Feb 2024 | 8,230 | 92,706 (0%) | 0% | 72.7 | 598,624 | Common Stock |
| Ted W. Love | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2024 | 2,996 | 2,996 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Love W. Ted | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2024 | 512 | 512 (0%) | 0% | 0 | Common Stock | |
| Dickinson Andrew D. | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 55,955 | 152,846 (0%) | 0% | 0 | Common Stock | |
| D. Andrew Dickinson | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 78.26 per share. | 31 Jan 2024 | 23,410 | 129,436 (0%) | 0% | 78.3 | 1,832,067 | Common Stock |
| O'Day Daniel | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 50,870 | 368,147 (0%) | 0% | 0 | Common Stock | |
| Johanna Mercier | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 78.26 per share. | 31 Jan 2024 | 22,509 | 113,147 (0%) | 0% | 78.3 | 1,761,554 | Common Stock |
| Parsey Merdad V. | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 56,624 | 126,325 (0%) | 0% | 0 | Common Stock | |
| Johanna Mercier | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 20,086 | 81,687 (0%) | 0% | 0 | Common Stock | |
| V. Parsey Merdad | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 78.26 per share. | 31 Jan 2024 | 23,709 | 102,616 (0%) | 0% | 78.3 | 1,855,466 | Common Stock |
| V. Parsey Merdad | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 20,229 | 69,701 (0%) | 0% | 0 | Common Stock | |
| Johanna Mercier | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 53,969 | 135,656 (0%) | 0% | 0 | Common Stock | |
| D. Andrew Dickinson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 19,006 | 96,891 (0%) | 0% | 0 | Common Stock | |
| Daniel O'Day | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 78.26 per share. | 31 Jan 2024 | 79,335 | 468,689 (0%) | 0% | 78.3 | 6,208,757 | Common Stock |
| Deborah Telman H. | EVP, Corporate Affairs & GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 4,646 | 11,728 (0%) | 0% | 0 | Common Stock | |
| Daniel O'Day | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 179,877 | 548,024 (0%) | 0% | 0 | Common Stock | |
| Deborah H. Telman | EVP, Corporate Affairs & GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2024 | 514 | 7,276 (0%) | 0% | - | Common Stock | |
| Telman H. Deborah | EVP, Corporate Affairs & GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2024 | 514 | 31,823 | - | - | Restricted Stock Unit | |
| H. Deborah Telman | EVP, Corporate Affairs & GC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.23 per share. | 25 Jan 2024 | 194 | 7,082 (0%) | 0% | 80.2 | 15,565 | Common Stock |
| Dickinson D. Andrew | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 85.78 per share. | 16 Jan 2024 | 5,000 | 101,534 (0%) | 0% | 85.8 | 428,900 | Common Stock |
| Johanna Mercier | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 85.23 per share. | 09 Jan 2024 | 8,242 | 82,729 (0%) | 0% | 85.2 | 702,466 | Common Stock |
| Lofton E. Kevin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Dec 2023 | 29 | 3,224 | - | - | Phantom Stock | |
| Sandra Patterson | SVP, Controllership | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2023 | 157 | 11,827 | - | - | Restricted Stock Unit | |
| Sandra Patterson | SVP, Controllership | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2023 | 117 | 37,376 (0%) | 0% | - | Common Stock | |
| Sandra Patterson | SVP, Controllership | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2023 | 181 | 37,259 (0%) | 0% | - | Common Stock | |
| Sandra Patterson | SVP, Controllership | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2023 | 117 | 11,984 | - | - | Restricted Stock Unit | |
| Sandra Patterson | SVP, Controllership | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2023 | 181 | 12,101 | - | - | Restricted Stock Unit | |
| Sandra Patterson | SVP, Controllership | Payment of exercise price or tax liability using portion of securities received from the company at price $ 91.85 per share. | 13 Dec 2023 | 157 | 37,078 (0%) | 0% | 91.9 | 14,421 | Common Stock |
| Sandra Patterson | SVP, Controllership | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.09 per share. | 13 Dec 2023 | 298 | 37,235 (0%) | 0% | 83.1 | 24,761 | Common Stock |
| Sandra Patterson | SVP, Controllership | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2023 | 157 | 37,533 (0%) | 0% | - | Common Stock | |
| O'Day Daniel | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2023 | 7,347 | 391,032 (0%) | 0% | - | Common Stock | |
| Sandra Patterson | SVP, Controllership | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2023 | 518 | 16,520 | - | - | Restricted Stock Unit | |
| Mercier Johanna | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2023 | 2,730 | 39,987 | - | - | Restricted Stock Unit | |
| Daniel O'Day | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.02 per share. | 10 Dec 2023 | 3,341 | 387,691 (0%) | 0% | 79.0 | 264,006 | Common Stock |
| Johanna Mercier | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.02 per share. | 10 Dec 2023 | 1,247 | 90,971 (0%) | 0% | 79.0 | 98,538 | Common Stock |
| Mercier Johanna | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2023 | 2,730 | 92,218 (0%) | 0% | - | Common Stock | |
| Daniel O'Day | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2023 | 7,347 | 110,892 | - | - | Restricted Stock Unit | |
| Sandra Patterson | SVP, Controllership | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2023 | 518 | 30,642 (0%) | 0% | - | Common Stock | |
| Sandra Patterson | SVP, Controllership | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.02 per share. | 10 Dec 2023 | 222 | 30,420 (0%) | 0% | 79.0 | 17,542 | Common Stock |
| Dickinson Andrew D. | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2023 | 2,617 | 38,834 | - | - | Restricted Stock Unit | |
| Parsey V. Merdad | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2023 | 2,779 | 40,975 | - | - | Restricted Stock Unit | |
| V. Parsey Merdad | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2023 | 2,779 | 72,909 (0%) | 0% | - | Common Stock | |
| Merdad Parsey V. | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.02 per share. | 10 Dec 2023 | 1,269 | 71,640 (0%) | 0% | 79.0 | 100,276 | Common Stock |
| Dickinson D. Andrew | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2023 | 2,617 | 107,728 (0%) | 0% | - | Common Stock | |
| Andrew Dickinson D. | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.02 per share. | 10 Dec 2023 | 1,194 | 106,534 (0%) | 0% | 79.0 | 94,350 | Common Stock |
| Dickinson Andrew D. | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Nov 2023 | 1,912 | 105,915 (0%) | 0% | - | Common Stock | |
| D. Andrew Dickinson | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.92 per share. | 10 Nov 2023 | 804 | 105,111 (0%) | 0% | 75.9 | 61,040 | Common Stock |
| D. Dickinson Andrew | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Nov 2023 | 1,912 | 41,451 | - | - | Restricted Stock Unit | |
| Deborah H. Telman | EVP, Corporate Affairs & GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Oct 2023 | 514 | 32,337 | - | - | Restricted Stock Unit | |
| Deborah H. Telman | EVP, Corporate Affairs & GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Oct 2023 | 514 | 7,005 (0%) | 0% | - | Common Stock | |
| Deborah H. Telman | EVP, Corporate Affairs & GC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 78.39 per share. | 25 Oct 2023 | 243 | 6,762 (0%) | 0% | 78.4 | 19,049 | Common Stock |
| Andrew D. Dickinson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 80.00 per share. | 17 Oct 2023 | 5,000 | 104,003 (0%) | 0% | 80.0 | 400,017 | Common Stock |
| Kevin E. Lofton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Sep 2023 | 31 | 3,194 | - | - | Phantom Stock | |
| Merdad V. Parsey | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 76.99 per share. | 12 Sep 2023 | 1,501 | 70,130 (0%) | 0% | 77.0 | 115,562 | Common Stock |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2023 | 2,619 | 110,206 (0%) | 0% | - | Common Stock | |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2023 | 2,619 | 43,363 | - | - | Restricted Stock Unit | |
| Andrew D. Dickinson | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 76.00 per share. | 10 Sep 2023 | 1,203 | 109,003 (0%) | 0% | 76 | 91,428 | Common Stock |
| Johanna Mercier | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 76.00 per share. | 10 Sep 2023 | 1,256 | 89,488 (0%) | 0% | 76 | 95,456 | Common Stock |
| Johanna Mercier | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2023 | 2,730 | 42,717 | - | - | Restricted Stock Unit | |
| Johanna Mercier | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2023 | 2,730 | 90,744 (0%) | 0% | - | Common Stock | |
| Merdad V. Parsey | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 76.00 per share. | 10 Sep 2023 | 1,278 | 71,631 (0%) | 0% | 76 | 97,128 | Common Stock |
| Merdad V. Parsey | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2023 | 2,779 | 43,754 | - | - | Restricted Stock Unit | |
| Merdad V. Parsey | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2023 | 2,779 | 72,909 (0%) | 0% | - | Common Stock | |
| Sandra Patterson | SVP, Controllership | Payment of exercise price or tax liability using portion of securities received from the company at price $ 76.00 per share. | 10 Sep 2023 | 149 | 30,124 (0%) | 0% | 76 | 11,324 | Common Stock |
| Sandra Patterson | SVP, Controllership | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2023 | 519 | 17,038 | - | - | Restricted Stock Unit | |
| Sandra Patterson | SVP, Controllership | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2023 | 519 | 30,273 (0%) | 0% | - | Common Stock | |
| Sandra Patterson | SVP, Controllership | Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.00 per share. | 10 Aug 2023 | 1,306 | 29,754 (0%) | 0% | 80 | 104,480 | Common Stock |
| Sandra Patterson | SVP, Controllership | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2023 | 4,484 | 31,060 (0%) | 0% | - | Common Stock | |
| Sandra Patterson | SVP, Controllership | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2023 | 4,484 | 17,557 | - | - | Restricted Stock Unit | |
| Deborah H. Telman | EVP, Corporate Affairs & GC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.23 per share. | 25 Jul 2023 | 4,174 | 4,433 (0%) | 0% | 77.2 | 322,358 | Common Stock |
| Deborah H. Telman | EVP, Corporate Affairs & GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jul 2023 | 2,058 | 6,491 (0%) | 0% | - | Common Stock | |
| Deborah H. Telman | EVP, Corporate Affairs & GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jul 2023 | 8,231 | 34,909 | - | - | Restricted Stock Unit | |
| Deborah H. Telman | EVP, Corporate Affairs & GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jul 2023 | 2,058 | 32,851 | - | - | Restricted Stock Unit | |
| Deborah H. Telman | EVP, Corporate Affairs & GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jul 2023 | 8,231 | 8,607 (0%) | 0% | - | Common Stock | |
| Johanna Mercier | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.66 per share. | 24 Jul 2023 | 3,174 | 48,326 (0%) | 0% | 77.7 | 246,493 | Common Stock |
| Johanna Mercier | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jul 2023 | 7,505 | 45,447 | - | - | Restricted Stock Unit | |
| Johanna Mercier | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jul 2023 | 7,505 | 51,500 (0%) | 0% | - | Common Stock | |
| Andrew D. Dickinson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 80.00 per share. | 20 Jul 2023 | 5,000 | 107,587 (0%) | 0% | 80 | 400,000 | Common Stock |
| Kevin E. Lofton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2023 | 30 | 3,163 | - | - | Phantom Stock | |
| Merdad V. Parsey | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 76.90 per share. | 13 Jun 2023 | 1,485 | 29,402 (0%) | 0% | 76.9 | 114,197 | Common Stock |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2023 | 2,618 | 74,920 (0%) | 0% | - | Common Stock | |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2023 | 2,618 | 45,982 | - | - | Restricted Stock Unit | |
| Andrew D. Dickinson | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 78.12 per share. | 10 Jun 2023 | 1,219 | 73,701 (0%) | 0% | 78.1 | 95,228 | Common Stock |
| Daniel O'Day | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 78.12 per share. | 10 Jun 2023 | 3,409 | 266,125 (0%) | 0% | 78.1 | 266,311 | Common Stock |
| Daniel O'Day | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2023 | 7,346 | 125,587 | - | - | Restricted Stock Unit | |
| Daniel O'Day | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2023 | 7,346 | 269,534 (0%) | 0% | - | Common Stock | |
| Johanna Mercier | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 78.12 per share. | 10 Jun 2023 | 1,272 | 43,995 (0%) | 0% | 78.1 | 99,369 | Common Stock |
| Johanna Mercier | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2023 | 2,730 | 45,267 (0%) | 0% | - | Common Stock | |
| Johanna Mercier | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2023 | 2,730 | 52,952 | - | - | Restricted Stock Unit | |
| Merdad V. Parsey | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 78.12 per share. | 10 Jun 2023 | 1,294 | 30,887 (0%) | 0% | 78.1 | 101,087 | Common Stock |
| Merdad V. Parsey | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2023 | 2,779 | 46,533 | - | - | Restricted Stock Unit | |
| Merdad V. Parsey | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2023 | 2,779 | 32,181 (0%) | 0% | - | Common Stock | |
| Sandra Patterson | SVP, Controllership | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2023 | 517 | 22,041 | - | - | Restricted Stock Unit | |
| Sandra Patterson | SVP, Controllership | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2023 | 517 | 26,729 (0%) | 0% | - | Common Stock | |
| Sandra Patterson | SVP, Controllership | Payment of exercise price or tax liability using portion of securities received from the company at price $ 78.12 per share. | 10 Jun 2023 | 153 | 26,576 (0%) | 0% | 78.1 | 11,952 | Common Stock |
| Anthony Welters | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2023 | 10,173 | 10,173 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Anthony Welters | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2023 | 1,887 | 7,922 (0%) | 0% | 0 | Common Stock | |
| Jacqueline K. Barton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2023 | 10,173 | 10,173 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Jacqueline K. Barton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2023 | 1,887 | 22,230 (0%) | 0% | 0 | Common Stock | |
| Javier J. Rodriguez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2023 | 10,173 | 10,173 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Javier J. Rodriguez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2023 | 1,887 | 8,392 (0%) | 0% | 0 | Common Stock | |
| Harish Manwani | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.45 per share. | 03 May 2023 | 368 | 11,014 (0%) | 0% | 79.5 | 29,238 | Common Stock |
| Harish Manwani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2023 | 10,173 | 10,173 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Harish Manwani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2023 | 1,887 | 11,382 (0%) | 0% | 0 | Common Stock | |
| Kevin E. Lofton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2023 | 1,887 | 92,653 (0%) | 0% | 0 | Common Stock | |
| Kevin E. Lofton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2023 | 10,173 | 10,173 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Kelly Anne Kramer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2023 | 1,887 | 15,284 | - | - | Restricted Stock Unit | |
| Kelly Anne Kramer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2023 | 10,173 | 10,173 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Sandra J. Horning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2023 | 1,887 | 3,631 (0%) | 0% | 0 | Common Stock | |
| Sandra J. Horning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2023 | 10,173 | 10,173 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Jeffrey A. Bluestone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2023 | 10,173 | 10,173 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Jeffrey A. Bluestone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2023 | 1,887 | 1,887 | - | - | Restricted Stock Unit | |
| Kevin E. Lofton | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 01 May 2023 | 12,868 | 90,766 (0%) | 0% | 0 | Common Stock | |
| Kevin E. Lofton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2023 | 28 | 3,132 | - | - | Phantom Stock | |
| Merdad V. Parsey | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 78.99 per share. | 13 Mar 2023 | 6,126 | 70,130 (0%) | 0% | 79.0 | 483,893 | Common Stock |
| Andrew D. Dickinson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2023 | 74,565 | 74,565 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2023 | 3,025 | 108,643 (0%) | 0% | - | Common Stock | |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2023 | 7,394 | 116,037 (0%) | 0% | - | Common Stock | |
| Andrew D. Dickinson | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.50 per share. | 10 Mar 2023 | 4,849 | 111,188 (0%) | 0% | 79.5 | 385,496 | Common Stock |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2023 | 3,025 | 39,644 | - | - | Restricted Stock Unit | |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2023 | 7,394 | 32,250 | - | - | Restricted Stock Unit | |
| Andrew D. Dickinson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2023 | 16,350 | 48,600 | - | - | Restricted Stock Unit | |
| Daniel O'Day | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2023 | 19,488 | 96,563 | - | - | Restricted Stock Unit | |
| Daniel O'Day | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.50 per share. | 10 Mar 2023 | 14,017 | 375,766 (0%) | 0% | 79.5 | 1,114,352 | Common Stock |
| Daniel O'Day | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2023 | 10,800 | 389,783 (0%) | 0% | - | Common Stock | |
| Daniel O'Day | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2023 | 10,800 | 85,763 | - | - | Restricted Stock Unit | |
| Daniel O'Day | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2023 | 47,170 | 132,933 | - | - | Restricted Stock Unit | |
| Daniel O'Day | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2023 | 19,488 | 378,983 (0%) | 0% | - | Common Stock | |
| Daniel O'Day | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2023 | 215,095 | 215,095 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Johanna Mercier | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2023 | 3,025 | 79,390 (0%) | 0% | - | Common Stock | |
| Johanna Mercier | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2023 | 7,951 | 87,341 (0%) | 0% | - | Common Stock | |
| Johanna Mercier | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.50 per share. | 10 Mar 2023 | 5,116 | 82,225 (0%) | 0% | 79.5 | 406,722 | Common Stock |
| Johanna Mercier | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2023 | 3,025 | 47,283 | - | - | Restricted Stock Unit | |
| Johanna Mercier | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2023 | 7,951 | 39,332 | - | - | Restricted Stock Unit | |
| Johanna Mercier | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2023 | 16,350 | 55,682 | - | - | Restricted Stock Unit | |
| Johanna Mercier | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2023 | 74,565 | 74,565 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Merdad V. Parsey | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2023 | 3,455 | 40,646 | - | - | Restricted Stock Unit | |
| Merdad V. Parsey | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.50 per share. | 10 Mar 2023 | 5,328 | 76,256 (0%) | 0% | 79.5 | 423,576 | Common Stock |
| Merdad V. Parsey | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2023 | 7,999 | 81,584 (0%) | 0% | - | Common Stock | |
| Merdad V. Parsey | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2023 | 3,455 | 73,585 (0%) | 0% | - | Common Stock | |
| Merdad V. Parsey | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2023 | 76,000 | 76,000 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Merdad V. Parsey | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2023 | 16,665 | 49,312 | - | - | Restricted Stock Unit | |
| Merdad V. Parsey | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2023 | 7,999 | 32,647 | - | - | Restricted Stock Unit | |
| Deborah H. Telman | EVP, Corporate Affairs & GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2023 | 10,220 | 43,140 | - | - | Restricted Stock Unit | |
| Deborah H. Telman | EVP, Corporate Affairs & GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2023 | 46,605 | 46,605 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Sandra Patterson | SVP, Controllership | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2023 | 1,320 | 16,428 | - | - | Restricted Stock Unit | |
| Sandra Patterson | SVP, Controllership | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2023 | 1,601 | 17,748 | - | - | Restricted Stock Unit | |
| Sandra Patterson | SVP, Controllership | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.50 per share. | 10 Mar 2023 | 801 | 26,212 (0%) | 0% | 79.5 | 63,680 | Common Stock |
| Sandra Patterson | SVP, Controllership | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2023 | 1,320 | 27,013 (0%) | 0% | - | Common Stock | |
| Sandra Patterson | SVP, Controllership | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2023 | 1,601 | 25,693 (0%) | 0% | - | Common Stock | |
| Sandra Patterson | SVP, Controllership | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2023 | 10,405 | 10,405 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Sandra Patterson | SVP, Controllership | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2023 | 6,130 | 22,558 | - | - | Restricted Stock Unit | |
| Kevin E. Lofton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2023 | 8,442 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Kevin E. Lofton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 52.38 per share. | 09 Mar 2023 | 8,442 | 8,442 (0%) | 0% | 52.4 | 442,192 | Common Stock |
| Daniel O'Day | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 11,362 | 116,051 | - | - | Restricted Stock Unit | |
| Daniel O'Day | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 11,362 | 364,337 (0%) | 0% | - | Common Stock | |
| Daniel O'Day | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.59 per share. | 01 Mar 2023 | 4,842 | 359,495 (0%) | 0% | 79.6 | 385,375 | Common Stock |
| Merdad V. Parsey | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 79.96 per share. | 01 Mar 2023 | 12,984 | 70,130 (0%) | 0% | 80.0 | 1,038,225 | Common Stock |
| Andrew D. Dickinson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 56.38 per share. | 15 Feb 2023 | 376 | 105,618 (0%) | 0% | 56.4 | 21,199 | Common Stock |
| Merdad V. Parsey | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 56.38 per share. | 15 Feb 2023 | 376 | 83,114 (0%) | 0% | 56.4 | 21,199 | Common Stock |
| Deborah H. Telman | EVP, Corporate Affairs & GC | Grant, award, or other acquisition of securities at price $ 56.38 per share. | 15 Feb 2023 | 376 | 376 (0%) | 0% | 56.4 | 21,199 | Common Stock |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2023 | 1,817 | 105,773 (0%) | 0% | - | Common Stock | |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2023 | 1,817 | 42,669 | - | - | Restricted Stock Unit | |
| Andrew D. Dickinson | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 86.36 per share. | 06 Feb 2023 | 531 | 105,242 (0%) | 0% | 86.4 | 45,857 | Common Stock |
| Diane E. Wilfong | SVP, Controller & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2023 | 1,864 | 32,575 (0%) | 0% | - | Common Stock | |
| Diane E. Wilfong | SVP, Controller & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2023 | 1,864 | 11,060 | - | - | Restricted Stock Unit | |
| Diane E. Wilfong | SVP, Controller & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 86.36 per share. | 06 Feb 2023 | 565 | 32,010 (0%) | 0% | 86.4 | 48,793 | Common Stock |
| Andrew D. Dickinson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2023 | 38,270 | 119,283 (0%) | 0% | 0 | Common Stock | |
| Andrew D. Dickinson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2023 | 27,932 | 81,013 (0%) | 0% | 0 | Common Stock | |
| Andrew D. Dickinson | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.02 per share. | 24 Jan 2023 | 15,327 | 103,956 (0%) | 0% | 84.0 | 1,287,775 | Common Stock |
| Diane E. Wilfong | SVP, Controller & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2023 | 1,784 | 27,855 (0%) | 0% | 0 | Common Stock | |
| Diane E. Wilfong | SVP, Controller & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.02 per share. | 24 Jan 2023 | 1,244 | 30,711 (0%) | 0% | 84.0 | 104,521 | Common Stock |
| Diane E. Wilfong | SVP, Controller & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2023 | 4,100 | 31,955 (0%) | 0% | 0 | Common Stock | |
| Daniel O'Day | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.02 per share. | 24 Jan 2023 | 59,078 | 352,975 (0%) | 0% | 84.0 | 4,963,734 | Common Stock |
| Daniel O'Day | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2023 | 78,370 | 275,406 (0%) | 0% | 0 | Common Stock | |
| Daniel O'Day | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2023 | 136,647 | 412,053 (0%) | 0% | 0 | Common Stock | |
| Johanna Mercier | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2023 | 38,270 | 91,690 (0%) | 0% | 0 | Common Stock | |
| Johanna Mercier | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.02 per share. | 24 Jan 2023 | 15,325 | 76,365 (0%) | 0% | 84.0 | 1,287,607 | Common Stock |
| Johanna Mercier | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2023 | 29,124 | 53,420 (0%) | 0% | 0 | Common Stock | |
| Merdad V. Parsey | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2023 | 29,644 | 56,772 (0%) | 0% | 0 | Common Stock | |
| Merdad V. Parsey | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.02 per share. | 24 Jan 2023 | 17,749 | 82,738 (0%) | 0% | 84.0 | 1,491,271 | Common Stock |
| Merdad V. Parsey | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2023 | 43,715 | 100,487 (0%) | 0% | 0 | Common Stock | |
| Merdad V. Parsey | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 85.33 per share. | 30 Dec 2022 | 553 | 45,556 (0%) | 0% | 85.3 | 47,187 | Common Stock |
| Kevin E. Lofton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2022 | 26 | 3,103 | - | - | Phantom Stock | |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2022 | 1,027 | 69,695 (0%) | 0% | 0 | Common Stock | |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2022 | 1,027 | 44,486 | - | - | Restricted Stock Unit | |
| Andrew D. Dickinson | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.97 per share. | 10 Dec 2022 | 480 | 69,215 (0%) | 0% | 88.0 | 42,226 | Common Stock |
| Diane E. Wilfong | SVP, Controller & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2022 | 318 | 28,651 (0%) | 0% | - | Common Stock | |
| Diane E. Wilfong | SVP, Controller & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2022 | 318 | 12,924 | - | - | Restricted Stock Unit | |
| Diane E. Wilfong | SVP, Controller & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.97 per share. | 10 Dec 2022 | 149 | 28,502 (0%) | 0% | 88.0 | 13,108 | Common Stock |
| Daniel O'Day | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2022 | 3,300 | 127,413 | - | - | Restricted Stock Unit | |
| Daniel O'Day | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.97 per share. | 10 Dec 2022 | 1,542 | 254,636 (0%) | 0% | 88.0 | 135,650 | Common Stock |
| Daniel O'Day | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2022 | 3,300 | 256,178 (0%) | 0% | - | Common Stock | |
| Johanna Mercier | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.97 per share. | 10 Dec 2022 | 463 | 40,430 (0%) | 0% | 88.0 | 40,730 | Common Stock |
| Johanna Mercier | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2022 | 990 | 50,308 | - | - | Restricted Stock Unit | |
| Johanna Mercier | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2022 | 990 | 40,893 (0%) | 0% | - | Common Stock | |
| Merdad V. Parsey | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2022 | 1,039 | 46,595 (0%) | 0% | - | Common Stock | |
| Merdad V. Parsey | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2022 | 1,039 | 44,101 | - | - | Restricted Stock Unit | |
| Merdad V. Parsey | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.97 per share. | 10 Dec 2022 | 486 | 46,109 (0%) | 0% | 88.0 | 42,753 | Common Stock |
| Andrew D. Dickinson | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 82.60 per share. | 10 Nov 2022 | 851 | 68,668 (0%) | 0% | 82.6 | 70,293 | Common Stock |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Nov 2022 | 1,912 | 45,513 | - | - | Restricted Stock Unit | |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Nov 2022 | 1,912 | 69,519 (0%) | 0% | - | Common Stock | |
| Merdad V. Parsey | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Nov 2022 | 5,099 | 45,140 | - | - | Restricted Stock Unit | |
| Merdad V. Parsey | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 82.60 per share. | 10 Nov 2022 | 2,268 | 45,556 (0%) | 0% | 82.6 | 187,337 | Common Stock |
| Merdad V. Parsey | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Nov 2022 | 5,099 | 47,824 (0%) | 0% | - | Common Stock | |
| Diane E. Wilfong | SVP, Controller & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 63.91 per share. | 09 Nov 2022 | 6,416 | 34,749 (0%) | 0% | 63.9 | 410,047 | Common Stock |
| Diane E. Wilfong | SVP, Controller & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Nov 2022 | 6,416 | 10,694 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Diane E. Wilfong | SVP, Controller & CAO | Sale of securities on an exchange or to another person at price $ 83.50 per share. | 09 Nov 2022 | 6,416 | 28,333 (0%) | 0% | 83.5 | 535,736 | Common Stock |
| Diane E. Wilfong | SVP, Controller & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 72.70 per share. | 01 Nov 2022 | 16,255 | 44,588 (0%) | 0% | 72.7 | 1,181,739 | Common Stock |
| Diane E. Wilfong | SVP, Controller & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2022 | 16,255 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Diane E. Wilfong | SVP, Controller & CAO | Sale of securities on an exchange or to another person at price $ 79.25 per share. | 01 Nov 2022 | 16,255 | 28,333 (0%) | 0% | 79.3 | 1,288,209 | Common Stock |
| Kevin E. Lofton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2022 | 35 | 3,077 | - | - | Phantom Stock | |
| Andrew D. Dickinson | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.28 per share. | 10 Sep 2022 | 476 | 67,607 (0%) | 0% | 65.3 | 31,073 | Common Stock |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2022 | 1,027 | 47,425 | - | - | Restricted Stock Unit | |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2022 | 1,027 | 68,083 (0%) | 0% | - | Common Stock | |
| Diane E. Wilfong | SVP, Controller & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2022 | 318 | 28,481 (0%) | 0% | - | Common Stock | |
| Diane E. Wilfong | SVP, Controller & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2022 | 318 | 13,242 | - | - | Restricted Stock Unit | |
| Diane E. Wilfong | SVP, Controller & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.28 per share. | 10 Sep 2022 | 148 | 28,333 (0%) | 0% | 65.3 | 9,661 | Common Stock |
| Daniel O'Day | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2022 | 3,301 | 254,406 (0%) | 0% | - | Common Stock | |
| Daniel O'Day | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2022 | 3,301 | 130,713 | - | - | Restricted Stock Unit | |
| Daniel O'Day | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.28 per share. | 10 Sep 2022 | 1,528 | 252,878 (0%) | 0% | 65.3 | 99,748 | Common Stock |
| Johanna Mercier | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2022 | 990 | 40,361 (0%) | 0% | - | Common Stock | |
| Johanna Mercier | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2022 | 990 | 51,298 | - | - | Restricted Stock Unit | |
| Johanna Mercier | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.28 per share. | 10 Sep 2022 | 458 | 39,903 (0%) | 0% | 65.3 | 29,898 | Common Stock |
| Merdad V. Parsey | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2022 | 1,039 | 43,206 (0%) | 0% | - | Common Stock | |
| Merdad V. Parsey | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.28 per share. | 10 Sep 2022 | 481 | 42,725 (0%) | 0% | 65.3 | 31,400 | Common Stock |
| Merdad V. Parsey | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2022 | 1,039 | 50,239 | - | - | Restricted Stock Unit | |
| Diane E. Wilfong | SVP, Controller & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2022 | 2,479 | 29,229 (0%) | 0% | - | Common Stock | |
| Diane E. Wilfong | SVP, Controller & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2022 | 2,479 | 13,560 | - | - | Restricted Stock Unit | |
| Diane E. Wilfong | SVP, Controller & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.14 per share. | 10 Aug 2022 | 1,066 | 28,163 (0%) | 0% | 63.1 | 67,307 | Common Stock |
| Johanna Mercier | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jul 2022 | 7,505 | 52,288 | - | - | Restricted Stock Unit | |
| Johanna Mercier | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.80 per share. | 24 Jul 2022 | 3,206 | 39,371 (0%) | 0% | 60.8 | 194,925 | Common Stock |
| Johanna Mercier | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jul 2022 | 7,505 | 42,577 (0%) | 0% | - | Common Stock | |
| Kevin E. Lofton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2022 | 35 | 3,042 | - | - | Phantom Stock | |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2022 | 1,026 | 69,025 (0%) | 0% | - | Common Stock | |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2022 | 1,026 | 48,452 | - | - | Restricted Stock Unit | |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2022 | 3,646 | 49,478 | - | - | Restricted Stock Unit | |
| Andrew D. Dickinson | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.74 per share. | 10 Jun 2022 | 1,969 | 67,056 (0%) | 0% | 60.7 | 119,597 | Common Stock |
| Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2022 | 3,646 | 67,999 (0%) | 0% | - | Common Stock | |
| Diane E. Wilfong | SVP, Controller & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.74 per share. | 10 Jun 2022 | 148 | 26,750 (0%) | 0% | 60.7 | 8,990 | Common Stock |
| Diane E. Wilfong | SVP, Controller & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2022 | 317 | 26,898 (0%) | 0% | - | Common Stock | |
| Diane E. Wilfong | SVP, Controller & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2022 | 317 | 16,039 | - | - | Restricted Stock Unit | |
| Daniel O'Day | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.74 per share. | 10 Jun 2022 | 1,539 | 251,105 (0%) | 0% | 60.7 | 93,479 | Common Stock |
| Daniel O'Day | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2022 | 3,300 | 134,014 | - | - | Restricted Stock Unit | |
| Daniel O'Day | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2022 | 3,300 | 252,644 (0%) | 0% | - | Common Stock | |
| Brett A. Pletcher | EVP,Corp Affairs & Gen Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2022 | 782 | 16,519 | - | - | Restricted Stock Unit | |
| Brett A. Pletcher | EVP,Corp Affairs & Gen Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2022 | 782 | 33,706 (0%) | 0% | - | Common Stock | |
| Brett A. Pletcher | EVP,Corp Affairs & Gen Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.74 per share. | 10 Jun 2022 | 280 | 33,426 (0%) | 0% | 60.7 | 17,007 | Common Stock |
| Johanna Mercier | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2022 | 990 | 35,534 (0%) | 0% | - | Common Stock | |
| Johanna Mercier | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2022 | 990 | 59,793 | - | - | Restricted Stock Unit | |
| Johanna Mercier | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.74 per share. | 10 Jun 2022 | 462 | 35,072 (0%) | 0% | 60.7 | 28,062 | Common Stock |
| Merdad V. Parsey | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2022 | 1,039 | 42,652 (0%) | 0% | - | Common Stock | |
| Merdad V. Parsey | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2022 | 1,039 | 51,278 | - | - | Restricted Stock Unit | |
| Merdad V. Parsey | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.74 per share. | 10 Jun 2022 | 485 | 42,167 (0%) | 0% | 60.7 | 29,459 | Common Stock |
| Anthony Welters | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 2,444 | 6,035 (0%) | 0% | 0 | Common Stock | |
| Anthony Welters | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 15,851 | 15,851 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Jacqueline K. Barton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 2,444 | 20,343 (0%) | 0% | 0 | Common Stock | |
| Jacqueline K. Barton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 15,851 | 15,851 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Javier J. Rodriguez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 15,851 | 15,851 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Javier J. Rodriguez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 2,444 | 6,505 (0%) | 0% | 0 | Common Stock | |
| Harish Manwani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 2,444 | 9,972 (0%) | 0% | 0 | Common Stock | |
| Harish Manwani | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.35 per share. | 05 May 2022 | 477 | 9,495 (0%) | 0% | 61.4 | 29,264 | Common Stock |
| Harish Manwani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 15,851 | 15,851 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Kevin E. Lofton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 2,444 | 95,192 (0%) | 0% | 0 | Common Stock | |
| Kevin E. Lofton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 15,851 | 15,851 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Kelly Anne Kramer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 15,851 | 15,851 | - | - | Non-qualified Stock Option (Right to Buy) |